Oral anticoagulants…who needs ‘em?

Patients with atrial fibrillation do! According to a new study, hundreds of thousands of patients aren’t receiving them each year. Folks with AFib are at a very high risk for stroke, and guess what? Oral anticoagulants—a.k.a. blood thinners—can reduce the risk by two-thirds and direct oral anticoagulants (DOACs) are proven to be just as effective, if not more so. No, this isn’t a groundbreaking new therapy. Quite the opposite. DOACs have been available since 2010. 655,000 patients were evaluated in the study and the data show that over a seven-year period, only 6 out of 10 patients with high stroke risk were prescribed these potentially life-saving meds. This guy sums it up best.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Ever wonder what your guts look like?

If you have an upcoming surgery, you might just get a sneak peek at your innards. Surgery performed on awake patients is on the upswing. InsightCity staff are split on whether this trend is terrifying or awesome (tell us your thoughts in this week’s FastPoll™). This technique is being used primarily in orthopedics but other specialties are moving in this direction. Benefits include reduced cost (no anesthesiologist necessary), faster recovery, patient feeling increased control, and curiosity satisfaction. I mean, who doesn’t want to see their colon up close and personal? Surgeons are going to have to work on their (operating) table manners… cursing when something goes awry or re-hashing last night’s partying will no longer be kosher. InsightCity assumes patients would rather not think of their surgeon binge-drinking like she’s on Grey’s Anatomy.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

2. I’d like one surgical procedure with a side of pain meds, please

Doctor: Unfortunately, you’ve been diagnosed with [insert scary disease here]. Call this number to schedule your procedure. See you in a month.

Patient: Huh? (shuffles out, looking bewildered)

New research is telling us that the above doctor-patient interaction is not what’s best for patients. Wuuuuuuut? No way. We’ll wait while you pick your jaws up from the floor… Data show that the more involved patients are in their health care decisions, the better. Presenting clear options, simplifying information, and making EMR data available to patients are ways physicians can involve patients in treatment decisions. Sounds to InsightCity like that leaves the ball mostly in the doctors’ court. Here’s hoping a little doctor-patient teamwork will leave patients feeling less like this.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

2. The war on drug stores heats up

Recent power plays in the prescription drug industry make J.R. Ewing’s actions seem like child’s play. If you don’t track the specialty pharmacy market, you should. This is a $100B industry that is growing rapidly. Think high-priced drugs used to treat Hep C and Cystic Fibrosis. According to the New York Times, large PBMs might be trying to force out independent specialty pharmacies. In Alabama, BCBS recently told patients that they cannot have their prescriptions filled at CVS. This is a big deal. It means patients have to sever long-standing relationships with pharmacists, especially difficult with specialty indications. This is all part of an emerging trend to narrow networks. Look it up. You will be glad you did and you’ll be smarter.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

2. Rocket Fuel Shortage in Cancer Moonshot

With so many Americans terrified of shots, the National Cancer Moonshot initiative may have trouble getting off the ground. A new study reveals only 40% of Americans hold a positive view of clinical trials, and just 4% of cancer patients enroll in a clinical trial annually. Yet, “when it comes to advancing cancer care, clinical research is the rocket fuel for better treatments, more accurate diagnoses and, ultimately, cures,” Dr. Jose Baselga, physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Institute said. Concerns about side-effects, safety and out-of-pocket costs combined with the fear of receiving a placebo instead of an active treatment mean the cancer community needs to do some myth busting about clinical trials before advancing towards a cure.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn